InsidersTradesSigma
Total declarations
Company
▲ Purchases (11 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
11
Disclosed sells
0
T+90 hit rate
43%
T+90 mean return
-8.0%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Rice William G., Chairman & CEO. Director active across 1 company, notably Aptose Biosciences Inc.. Aggregated, 13 reports have been published. Breakdown: 11 buys · 0 sell. Total volume traded: €175k. History available since 2 July 2021. The latest transaction was disclosed on 25 November 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations13 total
613,252 sharesCommon SharesSEC:0000912282-26-000897:0
100,000 shares@ US$0.2010.9% of flowCommon SharesSEC:0000912282-24-000829:0
Ideal exit: 22 Aug 2025 (T+270)
150,000 shares0Common SharesSEC:0001567619-23-001167:0
10,000 shares@ US$0.68343.9% of flowCommon SharesSEC:0001567619-22-017698:0
Ideal exit: 16 Jun 2023 (T+270)
10,000 shares@ US$0.96810.23% mcap6.1% of flowCommon SharesSEC:0001567619-22-012379:0
Ideal exit: 3 Mar 2023 (T+270)
13,183 shares@ US$1.5210.1% of flowCommon SharesSEC:0001567619-21-022227
Ideal exit: 12 Sept 2022 (T+270)
13,183 shares@ US$1.520.45% mcap11.9% of flowCommon SharesSEC:0001567619-21-022227:0
Ideal exit: 12 Sept 2022 (T+270)
17,822 shares@ US$1.1210.1% of flowCommon SharesSEC:0001567619-21-022080
Ideal exit: 11 Sept 2022 (T+270)
17,822 shares@ US$1.120.45% mcap11.9% of flowCommon SharesSEC:0001567619-21-022080:0
Ideal exit: 11 Sept 2022 (T+270)
8,643 shares@ US$2.310.45% mcap11.9% of flowCommon SharesSEC:0001567619-21-021215:0
Ideal exit: 23 Aug 2022 (T+270)
8,643 shares@ US$2.3110.2% of flowCommon SharesSEC:0001567619-21-021215
Ideal exit: 23 Aug 2022 (T+270)
6,081 shares@ US$3.28869.6% of flowCommon sharesSEC:0001567619-21-013023
Ideal exit: 29 Mar 2022 (T+270)
6,081 shares@ US$3.28860.43% mcap11.3% of flowCommon sharesSEC:0001567619-21-013023:0
Ideal exit: 29 Mar 2022 (T+270)
13 of 13 declarations
About Rice William G.
William G. Rice serves as Chairman, President & CEO of Aptose Biosciences Inc. In this role, he oversees the overall strategy and operations of the company. With extensive experience in the biopharmaceutical sector, William G. Rice is recognized for his ability to lead teams and develop innovative solutions. His commitment to operational excellence and shareholder value creation is central to his mission. William G. Rice plays a key role in guiding Aptose Biosciences Inc. towards sustainable growth.
